Therefore, boosting cholinergic neurotransmission after ischemic stroke likely modulates EZH2 expression/activity in nucleated blood cells, promoting an anti-inflammatory epigenetic program and helping to resolve harmful systemic inflammation. The gene discussed is EZH2; the disease is ischemic stroke.